TRexBio is headquartered in South San Francisco, California.
TRexBio’s initial public offering occurred on October 8, 2026.
TRexBio’s fiscal year ends December 31st.
TRexBio is traded on the NASDAQ Global Select Market under the ticker symbol TRXB.
89531N100
The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. The transfer agent and registrar’s mailing address is P.O. Box 43006, Providence, RI 02940-3006.
KPMG LLP is TRexBio’s independent registered public accounting firm.
TRexBio’s SEC filings, including quarterly and annual reports, can be viewed here.
TRexBio’s press releases can be viewed here.
You can submit queries to TRexBio’s investor relations department by contacting IR@trex.bio.